Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Results from Phase 1/2 Study of Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology 2025-06-10 23:52
Linical Celebrates 20 Years of Advancing Clinical Research and Patient Wellbeing 2025-06-10 09:00
BIOSeedin Innovation Partnering Conference 2025: Spotlight on China's Biopharma Trailblazers and Global Collaboration 2025-06-09 14:51
Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal Association 2025-06-09 14:16
The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC 2025-06-07 11:36
NEFECON®: New Results at ERA 2025 Demonstrate Treatment Benefit of the 'Treat Early' Strategy 2025-06-06 16:12
HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid 2025-06-06 14:00
Kelun-Biotech Announces Approximately US$250 Million Placement 2025-06-06 11:04
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer 2025-06-04 08:00
Telix Manufacturing Solutions (TMS) Established in Yokohama, Japan 2025-06-04 06:30
Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) 2025-06-03 14:00
International Healthcare Week 2025 - Innovate, Collaborate, And Elevate Healthcare In ASEAN And Beyond 2025-06-02 10:59
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies 2025-06-02 09:00
Teddy Laboratory (GuanHe Pharmaceuticals) Signs Strategic Cooperation Agreement with LabConnect to Forge a New Landscape in Laboratory Services Collaboration 2025-05-30 05:05
Dx&Vx Accelerates Development of Universal COVID-19 Vaccine 2025-05-29 21:03
Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein(a) in The National Lipid Association (NLA) Scientific Sessions 2025 2025-05-29 20:00
AI Meets Audit Powerhouse: Qualifyze Launches Quality Insights Platform to Help Global Pharma Manage Supplier Site Risk 2025-05-29 18:23
CPHI & PMEC China Sees Surge in International Attendance as Global Pharma Trade Outlook Strengthens 2025-05-29 12:43
Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies 2025-05-29 10:23
EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO 2025-05-28 14:13